FBXW7 and hepatocellular carcinoma: miR-155 can also promote hepatocellular carcinoma cell proliferation in vitro and tumorigenesis in vivo by inhibiting F-box and WD repeat domain containing 7 (FBXW7) expression (Tang et al., 2016[48]).